Application of prothrombin complex concentrate for reversal of direct oral anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonists

BACKGROUND: Prothrombin complex concentrate (PCC) is widely used to reverse the action of direct oral anticoagulants (DOACs) in accordance with current guidelines and because of a lack of specific reversal agents. Indications, clinical characteristics and patient outcomes of patients might differ in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Scand J Trauma Resusc Emerg Med
Asıl Yazarlar: Müller, Martin, Eastline, Jonathan, Nagler, Michael, Exadaktylos, Aristomenis K., Sauter, Thomas C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6480883/
https://ncbi.nlm.nih.gov/pubmed/31014373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13049-019-0625-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller